162
Views
25
CrossRef citations to date
0
Altmetric
Original Research

pH-Sensitive carboxymethyl chitosan-modified cationic liposomes for sorafenib and siRNA co-delivery

, , &
Pages 6185-6198 | Published online: 01 Oct 2015

References

  • LiJWangYZhuYRecent advances in delivery of drug-nucleic acid combinations for cancer treatmentJ Control Release2013172258960023624358
  • TsourisVJooMKKimSHNano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancersBiotechnol Adv20143251037105024924617
  • ResnierPMontierTMathieuVA review of the current status of siRNA nanomedicines in the treatment of cancerBiomaterials201334276429644323727262
  • OhYKParkTGsiRNA delivery systems for cancer treatmentAdv Drug Delivery Rev20096110850862
  • CostaPMCardosoALCustodiaCMiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: a new multimodal gene therapy approach for glioblastomaJ Control Release2015207313925861727
  • KatoTNatsumeATodaHEfficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cellsGene Ther201017111363137120520650
  • WangMLuXDongXpERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expressionWorld J Surg Oncol20151316625880226
  • MendonçaLSMoreiraJNde LimaMCPCo-encapsulation of anti-BCR-ABL siRNA and imatinib mesylate in transferrin receptor-targeted sterically stabilized liposomes for chronic myeloid leukemia treatmentBiotechnol Bioeng2010107588489320632368
  • ChenJSheuAYLiWGPoly(lactide-co-glycolide) microspheres for MRI-monitored transcatheter delivery of sorafenib to liver tumorsJ Control Release2014184101724727059
  • LiJ-MWangY-YZhaoM-XMultifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time trackingBiomaterials20123392780279022243797
  • BozzutoGMolinariALiposomes as nanomedical devicesInt J Nanomedicine20151097599925678787
  • MovahediFHuRGBeckerDLStimuli-responsive liposomes for the delivery of nucleic acid therapeuticsNanomedicine20151161575158425819885
  • ChenZHanLXuMRationally designed multitarget anticancer agentsCurr Med Chem201320131694171423410168
  • LiuJBoonkaewBAroraJComparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinomaJ Pharm Sci201510431187119625573425
  • ZhangHZhangFMYanSJPreparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticlesInt J Nanomedicine201272901291022787390
  • CaoHQWangYXHeXYCodelivery of sorafenib and curcumin by directed self-assembled nanoparticles enhances therapeutic effect on hepatocellular carcinomaMol Pharm201512392293125622075
  • ShenJSunHMengQSimultaneous inhibition of tumor growth and angiogenesis for resistant hepatocellular carcinoma by co-delivery of sorafenib and survivin small hairpin RNAMol Pharm201411103342335124495194
  • WangJLXiYLiuYLCombination of targeted PDT and anti-VEGF therapy for rat CNV by RGD-modified liposomal photocyanine and sorafenibInvest Ophthalmol Vis Sci201354137983798924204046
  • WangLGengDSuHSafe and efficient pH sensitive tumor targeting modified liposomes with minimal cytotoxicityColloids Surf B Biointerfaces201412339540225438693
  • HardiansyahAHuangLYYangMCNovel pH-sensitive drug carriers of carboxymethyl-hexanoyl chitosan (Chitosonic (R) Acid) modified liposomesRsc Advances20155302313423143
  • MouryaVInamdarNNTiwariACarboxymethyl chitosan and its applicationsAdv Mat Lett2010111133
  • LiuFXLiMLiuCXpH-Sensitive self-assembled carboxymethyl chitosan-modified DNA/polyethylenimine complexes for efficient gene deliveryJ Biomed Nanotechnol201410113397340626000398
  • LiuTWangMWangTCo-delivery of doxorubicin and siRNA by a simplified platform with oligodeoxynucleotides as a drug carrierColloids Surf B Biointerfaces201512653154025618822
  • WangMFLiuTXHanLQFunctionalized O-carboxymethyl-chitosan/polyethylenimine based novel dual pH-responsive nanocarriers for controlled co-delivery of DOX and genesPolymer Chemistry201561733243335
  • FengQYuMZWangJCSynergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticlesBiomaterials201435185028503824680191
  • ChenWYuanYChengDCo-delivery of doxorubicin and siRNA with reduction and pH dually sensitive nanocarrier for synergistic cancer therapySmall201410132678268724668891
  • LiuYFengLLiuTMultifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancerNanoscale2014663231324224500240
  • DengZJMortonSWBen-AkivaELayer-by-layer nanoparticles for systemic codelivery of an anticancer drug and siRNA for potential triple-negative breast cancer treatmentAcs Nano20137119571958424144228
  • DawidczykCMKimCParkJHState-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicinesJ Control Release201418713314424874289
  • WangFChenLZhangRRGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancerJ Control Release201419622223325456829
  • QuM-HZengR-FFangSLiposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancerInt J Pharm2014474111212225138252
  • FanYSahdevPOchylLJCationic liposome-hyaluronic acid hybrid nanoparticles for intranasal vaccination with subunit antigensJ Control Release201520812112925869965